Advertising Agencies
Compare Stocks
4 / 10Stock Comparison
HAO vs BIDU vs MGNI vs IQ
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
Advertising Agencies
Entertainment
HAO vs BIDU vs MGNI vs IQ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Advertising Agencies | Internet Content & Information | Advertising Agencies | Entertainment |
| Market Cap | $23M | $48.92B | $2.01B | $1.18B |
| Revenue (TTM) | $92M | $130.46B | $723M | $27.11B |
| Net Income (TTM) | $2M | $9.00B | $159M | $-390M |
| Gross Margin | 5.0% | 44.7% | 63.4% | 21.9% |
| Operating Margin | 3.2% | -2.6% | 14.8% | 1.7% |
| Forward P/E | 0.7x | 2.6x | 13.4x | 4.8x |
| Total Debt | $1M | $79.32B | $279M | $14.19B |
| Cash & Equiv. | $7M | $24.83B | $553M | $3.53B |
HAO vs BIDU vs MGNI vs IQ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 24 | May 26 | Return |
|---|---|---|---|
| Haoxi Health Techno… (HAO) | 100 | 0.4 | -99.6% |
| Baidu, Inc. (BIDU) | 100 | 132.8 | +32.8% |
| Magnite, Inc. (MGNI) | 100 | 158.2 | +58.2% |
| iQIYI, Inc. (IQ) | 100 | 36.1 | -63.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HAO vs BIDU vs MGNI vs IQ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HAO carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 71.9%, EPS growth 11.0%, 3Y rev CAGR 55.7%
- Lower volatility, beta 0.65, Low D/E 10.7%, current ratio 3.98x
- Beta 0.65, current ratio 3.98x
- 71.9% revenue growth vs IQ's -8.3%
BIDU is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 3 yrs, beta 1.41
- +61.3% vs HAO's -57.3%
MGNI is the clearest fit if your priority is long-term compounding.
- -4.7% 10Y total return vs BIDU's -17.5%
- 22.0% margin vs IQ's -1.4%
IQ lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 71.9% revenue growth vs IQ's -8.3% | |
| Value | Lower P/E (0.7x vs 13.4x) | |
| Quality / Margins | 22.0% margin vs IQ's -1.4% | |
| Stability / Safety | Beta 0.65 vs MGNI's 1.63, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +61.3% vs HAO's -57.3% | |
| Efficiency (ROA) | 7.2% ROA vs IQ's -0.9%, ROIC 36.6% vs 5.8% |
HAO vs BIDU vs MGNI vs IQ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
HAO vs BIDU vs MGNI vs IQ — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MGNI leads in 1 of 6 categories
IQ leads 1 • HAO leads 1 • BIDU leads 1 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MGNI leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BIDU is the larger business by revenue, generating $130.5B annually — 1425.2x HAO's $92M. MGNI is the more profitable business, keeping 22.0% of every revenue dollar as net income compared to IQ's -1.4%. On growth, MGNI holds the edge at +5.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $92M | $130.5B | $723M | $27.1B |
| EBITDAEarnings before interest/tax | $3M | $4.9B | $145M | $6.3B |
| Net IncomeAfter-tax profit | $2M | $9.0B | $159M | -$390M |
| Free Cash FlowCash after capex | -$4M | -$15.7B | $44M | $466M |
| Gross MarginGross profit ÷ Revenue | +5.0% | +44.7% | +63.4% | +21.9% |
| Operating MarginEBIT ÷ Revenue | +3.2% | -2.6% | +14.8% | +1.7% |
| Net MarginNet income ÷ Revenue | +1.7% | +6.9% | +22.0% | -1.4% |
| FCF MarginFCF ÷ Revenue | -4.6% | -12.0% | +6.1% | +1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.9% | -7.1% | +5.5% | -7.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -120.3% | -2.6% | +142.9% | -2.1% |
Valuation Metrics
IQ leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 0.7x trailing earnings, HAO trades at a 95% valuation discount to MGNI's 14.7x P/E. On an enterprise value basis, HAO's 10.1x EV/EBITDA is more attractive than MGNI's 11.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $23M | $48.9B | $2.0B | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $17M | $56.9B | $1.7B | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | 0.67x | 14.44x | 14.74x | 10.69x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 2.58x | 13.45x | 4.83x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.24x | — | — |
| EV / EBITDAEnterprise value multiple | 10.05x | 10.79x | 11.43x | 10.27x |
| Price / SalesMarket cap ÷ Revenue | 0.47x | 2.50x | 2.81x | 0.27x |
| Price / BookPrice ÷ Book value/share | 0.77x | 1.17x | 2.33x | 0.60x |
| Price / FCFMarket cap ÷ FCF | — | 25.41x | 12.11x | 4.13x |
Profitability & Efficiency
HAO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MGNI delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-3 for IQ. HAO carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQ's 1.06x. On the Piotroski fundamental quality scale (0–9), MGNI scores 6/9 vs HAO's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +8.4% | +3.1% | +18.6% | -2.9% |
| ROA (TTM)Return on assets | +7.2% | +2.0% | +5.3% | -0.9% |
| ROICReturn on invested capital | +36.6% | +4.8% | +9.5% | +5.8% |
| ROCEReturn on capital employed | +25.4% | +6.3% | +7.3% | +7.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.11x | 0.28x | 0.30x | 1.06x |
| Net DebtTotal debt minus cash | -$5M | $54.5B | -$275M | $10.7B |
| Cash & Equiv.Liquid assets | $7M | $24.8B | $553M | $3.5B |
| Total DebtShort + long-term debt | $1M | $79.3B | $279M | $14.2B |
| Interest CoverageEBIT ÷ Interest expense | 60.28x | 9.71x | 4.03x | 0.77x |
Total Returns (Dividends Reinvested)
Evenly matched — BIDU and MGNI each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BIDU five years ago would be worth $7,302 today (with dividends reinvested), compared to $54 for HAO. Over the past 12 months, BIDU leads with a +61.3% total return vs HAO's -57.3%. The 3-year compound annual growth rate (CAGR) favors MGNI at 16.7% vs HAO's -82.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -31.9% | -6.9% | -12.8% | -40.4% |
| 1-Year ReturnPast 12 months | -57.3% | +61.3% | +12.6% | -36.0% |
| 3-Year ReturnCumulative with dividends | -99.5% | +14.2% | +58.7% | -79.6% |
| 5-Year ReturnCumulative with dividends | -99.5% | -27.0% | -60.9% | -91.2% |
| 10-Year ReturnCumulative with dividends | -96.7% | -17.5% | -4.7% | -92.2% |
| CAGR (3Y)Annualised 3-year return | -82.5% | +4.5% | +16.7% | -41.1% |
Risk & Volatility
Evenly matched — HAO and BIDU each lead in 1 of 2 comparable metrics.
Risk & Volatility
HAO is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than MGNI's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BIDU currently trades 84.6% from its 52-week high vs HAO's 30.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.65x | 1.41x | 1.63x | 1.43x |
| 52-Week HighHighest price in past year | $2.31 | $165.30 | $26.65 | $2.84 |
| 52-Week LowLowest price in past year | $0.45 | $81.17 | $10.82 | $1.07 |
| % of 52W HighCurrent price vs 52-week peak | +30.6% | +84.6% | +52.5% | +42.6% |
| RSI (14)Momentum oscillator 0–100 | 24.6 | 69.1 | 55.4 | 45.6 |
| Avg Volume (50D)Average daily shares traded | 26K | 2.0M | 2.1M | 11.1M |
Analyst Outlook
BIDU leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: BIDU as "Buy", MGNI as "Buy", IQ as "Buy". Consensus price targets imply 78.5% upside for IQ (target: $2) vs 10.6% for BIDU (target: $155).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $154.70 | $18.00 | $2.16 |
| # AnalystsCovering analysts | — | 53 | 31 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 3 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.9% | +2.3% | 0.0% |
MGNI leads in 1 of 6 categories (Income & Cash Flow). IQ leads in 1 (Valuation Metrics). 2 tied.
HAO vs BIDU vs MGNI vs IQ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HAO or BIDU or MGNI or IQ a better buy right now?
For growth investors, Haoxi Health Technology Limited (HAO) is the stronger pick with 71.
9% revenue growth year-over-year, versus -8. 3% for iQIYI, Inc. (IQ). Haoxi Health Technology Limited (HAO) offers the better valuation at 0. 7x trailing P/E, making it the more compelling value choice. Analysts rate Baidu, Inc. (BIDU) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HAO or BIDU or MGNI or IQ?
On trailing P/E, Haoxi Health Technology Limited (HAO) is the cheapest at 0.
7x versus Magnite, Inc. at 14. 7x. On forward P/E, Baidu, Inc. is actually cheaper at 2. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HAO or BIDU or MGNI or IQ?
Over the past 5 years, Baidu, Inc.
(BIDU) delivered a total return of -27. 0%, compared to -99. 5% for Haoxi Health Technology Limited (HAO). Over 10 years, the gap is even starker: MGNI returned -4. 7% versus HAO's -96. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HAO or BIDU or MGNI or IQ?
By beta (market sensitivity over 5 years), Haoxi Health Technology Limited (HAO) is the lower-risk stock at 0.
65β versus Magnite, Inc. 's 1. 63β — meaning MGNI is approximately 152% more volatile than HAO relative to the S&P 500. On balance sheet safety, Haoxi Health Technology Limited (HAO) carries a lower debt/equity ratio of 11% versus 106% for iQIYI, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HAO or BIDU or MGNI or IQ?
By revenue growth (latest reported year), Haoxi Health Technology Limited (HAO) is pulling ahead at 71.
9% versus -8. 3% for iQIYI, Inc. (IQ). On earnings-per-share growth, the picture is similar: Haoxi Health Technology Limited grew EPS 1105% year-over-year, compared to -60. 7% for iQIYI, Inc.. Over a 3-year CAGR, HAO leads at 55. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HAO or BIDU or MGNI or IQ?
Magnite, Inc.
(MGNI) is the more profitable company, earning 20. 3% net margin versus 2. 6% for iQIYI, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BIDU leads at 16. 0% versus 3. 5% for HAO. At the gross margin level — before operating expenses — MGNI leads at 62. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HAO or BIDU or MGNI or IQ more undervalued right now?
On forward earnings alone, Baidu, Inc.
(BIDU) trades at 2. 6x forward P/E versus 13. 4x for Magnite, Inc. — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IQ: 78. 5% to $2. 16.
08Which pays a better dividend — HAO or BIDU or MGNI or IQ?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is HAO or BIDU or MGNI or IQ better for a retirement portfolio?
For long-horizon retirement investors, Haoxi Health Technology Limited (HAO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
65)). Magnite, Inc. (MGNI) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HAO: -96. 7%, MGNI: -4. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HAO and BIDU and MGNI and IQ?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HAO is a small-cap high-growth stock; BIDU is a mid-cap deep-value stock; MGNI is a small-cap deep-value stock; IQ is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.